Changes in the fatty acid composition of plasma lipoproteins during administration of Intralipid to a patient with essential fatty acid deficiency.
D002784:Cholesterol / Q000097:blood; D004338:Drug Combinations; D004952:Esters / Q000097:blood; D005227:Fatty Acids / Q000097:blood*; D005228:Fatty Acids, Essential / Q000172:deficiency*; D005260:Female; D005990:Glycerol / Q000008:administration & dosage*; D006801:Humans; D008041:Linoleic Acids / Q000097:blood; D008074:Lipoproteins / Q000097:blood*; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008875:Middle Aged; D009821:Oils / Q000008:administration & dosage*; D010713:Phosphatidylcholines / Q000008:administration & dosage* / Q000097:blood; D014280:Triglycerides / Q000097:blood
D004338:Drug Combinations; D004952:Esters; D005227:Fatty Acids; D005228:Fatty Acids, Essential; D008041:Linoleic Acids; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009821:Oils; D010713:Phosphatidylcholines; D014280:Triglycerides; D002784:Cholesterol; D005990:Glycerol